Scientists hunt for hidden clues to stop a deadly pregnancy complication

NCT ID NCT06232668

Recruiting now Knowledge-focused Sponsor: Carlos Simon Foundation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find early molecular signs of preeclampsia, a serious pregnancy condition, by examining tissue from the womb (maternal-fetal interface) collected between weeks 9 and 15 of pregnancy. Researchers will compare samples from women who later develop preeclampsia with those who have healthy pregnancies. The goal is to identify markers that could lead to better screening and prevention strategies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA

Contacts and locations

Locations

Hospital Clinico Universitario Virgen de la Arrixaca
RECRUITING

Murcia, Murcia, Spain
Hospital General Universitario Dr. Balmis
RECRUITING

Alicante, Alicante, Spain
Hospital Universitario de Canarias
RECRUITING

Santa Cruz de Tenerife, Santa Cruz de Tenerife, Spain
Hospital Universitario de Torrejón
NOT_YET_RECRUITING

Madrid, Madrid, Spain
Hospital Universitario y Politécnico La Fe
RECRUITING

Valencia, Valencia, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.